CN1900056A - 肌酸乙酯盐酸盐的制备方法 - Google Patents
肌酸乙酯盐酸盐的制备方法 Download PDFInfo
- Publication number
- CN1900056A CN1900056A CN 200610014797 CN200610014797A CN1900056A CN 1900056 A CN1900056 A CN 1900056A CN 200610014797 CN200610014797 CN 200610014797 CN 200610014797 A CN200610014797 A CN 200610014797A CN 1900056 A CN1900056 A CN 1900056A
- Authority
- CN
- China
- Prior art keywords
- creatine
- reaction
- temperature
- ester hydrochloride
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 ethyl creatine hydrochloride Chemical compound 0.000 title abstract description 10
- 238000004519 manufacturing process Methods 0.000 title description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N anhydrous creatine Natural products NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims abstract description 101
- 229960003624 creatine Drugs 0.000 claims abstract description 51
- 239000006046 creatine Substances 0.000 claims abstract description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000003756 stirring Methods 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000010992 reflux Methods 0.000 claims abstract description 8
- 239000012266 salt solution Substances 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 37
- 150000002148 esters Chemical class 0.000 claims description 23
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 13
- 229960004756 ethanol Drugs 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 239000013078 crystal Substances 0.000 abstract description 2
- 239000011259 mixed solution Substances 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 7
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 7
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 6
- 239000012346 acetyl chloride Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000011229 interlayer Substances 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- MEJYXFHCRXAUIL-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;hydrate Chemical compound O.NC(=N)N(C)CC(O)=O MEJYXFHCRXAUIL-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 229960004826 creatine monohydrate Drugs 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000018360 neuromuscular disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100147976A CN100371316C (zh) | 2006-07-19 | 2006-07-19 | 肌酸乙酯盐酸盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100147976A CN100371316C (zh) | 2006-07-19 | 2006-07-19 | 肌酸乙酯盐酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1900056A true CN1900056A (zh) | 2007-01-24 |
CN100371316C CN100371316C (zh) | 2008-02-27 |
Family
ID=37656079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100147976A Active CN100371316C (zh) | 2006-07-19 | 2006-07-19 | 肌酸乙酯盐酸盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100371316C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391156A (zh) * | 2011-09-07 | 2012-03-28 | 沈军 | 胍基衍生物肌酸盐酸盐的制备方法 |
CN102976978A (zh) * | 2012-12-26 | 2013-03-20 | 天津天成制药有限公司 | L-精氨酸乙酯盐酸盐的制备方法 |
CN101066938B (zh) * | 2007-06-15 | 2013-09-11 | 上海博速医药科技有限公司 | 一种肌酸酯盐酸盐的制备方法 |
EP2692719A1 (en) | 2012-07-30 | 2014-02-05 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof |
CN108929249A (zh) * | 2018-09-07 | 2018-12-04 | 泰山医学院 | 一种肌酸乙酯盐酸盐的合成新工艺 |
CN116143663A (zh) * | 2023-01-19 | 2023-05-23 | 安徽泰格生物科技有限公司 | 一种肌酸乙酯盐酸盐的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6897334B2 (en) * | 2003-08-25 | 2005-05-24 | Board Of Regents Of The University Of Nebraska | Production of creatine esters using in situ acid production |
CN1240676C (zh) * | 2004-09-17 | 2006-02-08 | 太仓市新毛涤纶化工总厂 | 肌酸乙酯盐酸盐的制造工艺 |
-
2006
- 2006-07-19 CN CNB2006100147976A patent/CN100371316C/zh active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101066938B (zh) * | 2007-06-15 | 2013-09-11 | 上海博速医药科技有限公司 | 一种肌酸酯盐酸盐的制备方法 |
CN102391156A (zh) * | 2011-09-07 | 2012-03-28 | 沈军 | 胍基衍生物肌酸盐酸盐的制备方法 |
CN102391156B (zh) * | 2011-09-07 | 2013-11-27 | 沈军 | 胍基衍生物肌酸盐酸盐的制备方法 |
EP2692719A1 (en) | 2012-07-30 | 2014-02-05 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof |
WO2014019855A1 (en) | 2012-07-30 | 2014-02-06 | Commissariat à l'énergie atomique et aux énergies alternatives | Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof |
US10144705B2 (en) | 2012-07-30 | 2018-12-04 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof |
CN102976978A (zh) * | 2012-12-26 | 2013-03-20 | 天津天成制药有限公司 | L-精氨酸乙酯盐酸盐的制备方法 |
CN108929249A (zh) * | 2018-09-07 | 2018-12-04 | 泰山医学院 | 一种肌酸乙酯盐酸盐的合成新工艺 |
CN108929249B (zh) * | 2018-09-07 | 2021-10-08 | 山东第一医科大学(山东省医学科学院) | 一种肌酸乙酯盐酸盐的合成工艺 |
CN116143663A (zh) * | 2023-01-19 | 2023-05-23 | 安徽泰格生物科技有限公司 | 一种肌酸乙酯盐酸盐的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100371316C (zh) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100371316C (zh) | 肌酸乙酯盐酸盐的制备方法 | |
US7622576B1 (en) | Halide-free glucosamine base and method of preparation | |
CN101307088A (zh) | 一种胆酸偶联物的制备方法 | |
CN110256517A (zh) | 一种从猪胆汁或下脚料中生产高纯度鹅去氧胆酸的方法 | |
CN104829495A (zh) | 一种双组份溶剂制备高纯度高收率盐酸二甲双胍的方法 | |
CN101117334A (zh) | 合成l-肌肽的新方法 | |
JPH03128392A (ja) | 3α,7β―ジヒドロキシ―12―ケト―5β―コラン酸の精製方法 | |
CN102775450B (zh) | 一种1,6-脱水-2-叠氮-2-脱氧-β-D-吡喃葡萄糖的制备方法 | |
CN101270074A (zh) | 一种高纯度米格列奈钙的制备方法 | |
CN104744390A (zh) | 一种依折麦布中间体酮的制备方法 | |
CN101190889B (zh) | 一种精氨酸布洛芬盐的制备方法 | |
CN102190644B (zh) | 手性3-羟基吡啶-4-酮类衍生物及其合成和用途 | |
CN113620855A (zh) | 一种伊万卡塞中间体ii及其合成方法 | |
CN104151396B (zh) | 混合溶剂中催化合成s‑乙酰基‑l‑谷胱甘肽的方法 | |
CN110041233B (zh) | N-脂肪酰基-n-甲基牛磺酸钠的制备方法 | |
CN101844991B (zh) | L-亮氨酸硝酸盐的制备方法 | |
CN108299251B (zh) | 格列美脲杂质的制备方法 | |
CN102344392B (zh) | 一种蛋白脱乙酰酶抑制剂伏立诺他的精制方法 | |
CN105949127B (zh) | 一种咪唑苯脲的提纯方法 | |
CN105085496A (zh) | 一种制备拉帕替尼的方法和中间体 | |
RU2720985C1 (ru) | Способ получения гамма-бутиробетаина и его гидрохлорида | |
CN114436872B (zh) | 一种低成本的l-肉碱制备方法 | |
CN101817758B (zh) | L-缬氨酸硝酸盐的制备方法 | |
JP3425664B2 (ja) | カルシウム吸収を促進する多糖類食品素材およびその製造方法 | |
CN107512709A (zh) | 一种三棱柱自组装蝴蝶结状羟基磷酸铜电极材料的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Process for preparing ethyl creatine hydrochloride Effective date of registration: 20121024 Granted publication date: 20080227 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2012990000633 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20131021 Granted publication date: 20080227 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2012990000633 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Process for preparing ethyl creatine hydrochloride Effective date of registration: 20131108 Granted publication date: 20080227 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2013990000831 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PP01 | Preservation of patent right |
Effective date of registration: 20140526 Granted publication date: 20080227 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20150526 Granted publication date: 20080227 |
|
PP01 | Preservation of patent right |
Effective date of registration: 20150526 Granted publication date: 20080227 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20151126 Granted publication date: 20080227 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PP01 | Preservation of patent right |
Effective date of registration: 20160414 Granted publication date: 20080227 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20161014 Granted publication date: 20080227 |
|
PP01 | Preservation of patent right |
Effective date of registration: 20161102 Granted publication date: 20080227 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20170502 Granted publication date: 20080227 |
|
PD01 | Discharge of preservation of patent | ||
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20170519 Granted publication date: 20080227 |